Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Theodore Sand"'
Autor:
Linda Black, Shelly Zacharias, Mark Hughes, Rachel Bautista, Nopmanee Taechangam, Theodore Sand
Publikováno v:
Frontiers in Veterinary Science, Vol 9 (2022)
Canine atopic dermatitis (cAD) is a common allergic skin condition among dogs that may respond to treatment with mesenchymal stromal cells (MSCs). The aim of this pilot study was to evaluate the safety and efficacy of allogeneic uterine tissue-derive
Externí odkaz:
https://doaj.org/article/0b4804eb4b954fe78cd10f818d22ad40
Autor:
Kenneth Mautner, Matthew Lucas, Ian Stemper, Shane A. Shapiro, Joshua A Hirsch, Christopher Gharibo, Maanasa V Manchikanti, Kenneth D. Candido, Theodore Sand, Alaa Abd-Elsayed, Sudhir Diwan, Sarah M. Pastoriza, Michael Fredericson, Ramarao Pasupuleti, Alan D. Kaye, Christopher J. Centeno, Cameron Cartier, Mahendra R Sanapati, Douglas P. Beall, Nebojsa Nick Knezevic, Vidyasagar Pampati, Samuel Murala, Philippe Hernigou, R Amadeus Mason, Steve M. Aydin, Mairin A Jerome, Joanne Borg-Stein, Cyril Philip, Amol Soin, Ricardo M. Buenaventura, Joseph A Cabaret, Gerard A. Malanga, Radomir Kosanovic, Zachary Fausel, Aaron K. Calodney, Rinoo V. Shah, Ehren Dodson, Adam M. Kaye, Laxmaiah Manchikanti, Mayank Gupta, Bradley W. Wargo, Sheri L. Albers, Annu Navani, Don Buford, Richard E. Latchaw, Sairam Atluri
Publikováno v:
Pain Physician. :E85-E131
BACKGROUND The use of bone marrow concentrate (BMC) for treatment of musculoskeletal disorders has become increasingly popular over the last several years, as technology has improved along with the need for better solutions for these pathologies. The
Publikováno v:
Research in veterinary science. 141
Chronic kidney disease (CKD) is a common condition and leading cause of mortality in cats. Mesenchymal stromal cells (MSCs) may have a therapeutic effect on CKD. The aim of this pilot study was to determine efficacy of systemically-administered allog
Autor:
Laxmaiah, Manchikanti, Christopher J, Centeno, Sairam, Atluri, Sheri L, Albers, Shane, Shapiro, Gerard A, Malanga, Alaa, Abd-Elsayed, Mairin, Jerome, Joshua A, Hirsch, Alan D, Kaye, Steve M, Aydin, Douglas, Beall, Don, Buford, Joanne, Borg-Stein, Ricardo M, Buenaventura, Joseph A, Cabaret, Aaron K, Calodney, Kenneth D, Candido, Cameron, Cartier, Richard, Latchaw, Sudhir, Diwan, Ehren, Dodson, Zachary, Fausel, Michael, Fredericson, Christopher G, Gharibo, Mayank, Gupta, Adam M, Kaye, Nebojsa Nick, Knezevic, Radomir, Kosanovic, Matthew, Lucas, Maanasa V, Manchikanti, R Amadeus, Mason, Kenneth, Mautner, Samuel, Murala, Annu, Navani, Vidyasagar, Pampati, Sarah, Pastoriza, Ramarao, Pasupuleti, Cyril, Philip, Mahendra R, Sanapati, Theodore, Sand, Rinoo V, Shah, Amol, Soin, Ian, Stemper, Bradley W, Wargo, Philippe, Hernigou
Publikováno v:
Pain physician. 23(2)
The use of bone marrow concentrate (BMC) for treatment of musculoskeletal disorders has become increasingly popular over the last several years, as technology has improved along with the need for better solutions for these pathologies. The use of cel
Autor:
David C. Karli, Theodore Sand
Publikováno v:
PM&R. 9
Publikováno v:
International orthopaedics. 41(10)
The purpose of this study is to assess safety and feasibility of intradiscal bone marrow concentrate (BMC) injections to treat low back discogenic pain as an alternative to surgery with three year minimum follow-up. A total of 26 patients suffering f
Publikováno v:
Current Orthopaedic Practice. 25:164-168
Autor:
Kathy E. Mitchell, Jeanell R. Tucker, Linda Black, Steven M. Hoynowski, Theodore Sand, Matthew T. Leming, Bryn M. Gardner, Madeline M. Fry
Publikováno v:
Biochemical and Biophysical Research Communications. 362:347-353
Stem cells are being evaluated in numerous human clinical trials and are commercially used in veterinary medicine to treat horses and dogs. Stem cell differentiation, homing to disease sites, growth and cytokine factor modulation, and low antigenicit
Publikováno v:
International orthopaedics. 40(1)
The purpose of this study is to assess safety and feasibility of intradiscal bone marrow concentrate (BMC) injections to treat discogenic pain as an alternative to surgery. A total of 26 patients (11 male, 15 female, aged 18–61 years, 13 single lev
Publikováno v:
Stem cells (Dayton, Ohio). 33(1)
Degenerative disc disease (DDD) induces chronic back pain with limited nonsurgical options. In this open label pilot study, 26 patients (median age 40 years; range 18–61) received autologous bone marrow concentrate (BMC) disc injections (13 one lev